These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 8401232)
1. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Mesters RM; Heeb MJ; Griffin JH Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232 [TBL] [Abstract][Full Text] [Related]
2. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Mesters RM; Heeb MJ; Griffin JH Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484 [TBL] [Abstract][Full Text] [Related]
3. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. Heeb MJ; Kojima Y; Hackeng TM; Griffin JH Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912 [TBL] [Abstract][Full Text] [Related]
4. Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. Mesters RM; Houghten RA; Griffin JH J Biol Chem; 1991 Dec; 266(36):24514-9. PubMed ID: 1761551 [TBL] [Abstract][Full Text] [Related]
5. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va. Gale AJ; Sun X; Heeb MJ; Griffin JH Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985 [TBL] [Abstract][Full Text] [Related]
6. A prothrombinase-based assay for detection of resistance to activated protein C. Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278 [TBL] [Abstract][Full Text] [Related]
7. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells. Hockin MF; Kalafatis M; Shatos M; Mann KG Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254 [TBL] [Abstract][Full Text] [Related]
8. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation. Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573 [TBL] [Abstract][Full Text] [Related]
9. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X. Kalafatis M; Beck DO Biochemistry; 2002 Oct; 41(42):12715-28. PubMed ID: 12379114 [TBL] [Abstract][Full Text] [Related]
10. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation. Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585 [TBL] [Abstract][Full Text] [Related]
11. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. Hackeng TM; van 't Veer C; Meijers JC; Bouma BN J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724 [TBL] [Abstract][Full Text] [Related]
12. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets. Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137 [TBL] [Abstract][Full Text] [Related]
13. C-terminal residues 621-635 of protein S are essential for binding to factor Va. Heeb MJ; Kojima Y; Rosing J; Tans G; Griffin JH J Biol Chem; 1999 Dec; 274(51):36187-92. PubMed ID: 10593904 [TBL] [Abstract][Full Text] [Related]
14. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C. Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation. Rintelen C; Yegneswaran S; Griffin JH Thromb Haemost; 2001 Feb; 85(2):274-9. PubMed ID: 11246547 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system. Hayashi T; Nishioka J; Suzuki K Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347 [TBL] [Abstract][Full Text] [Related]
17. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. Heeb MJ; Mesters RM; Tans G; Rosing J; Griffin JH J Biol Chem; 1993 Feb; 268(4):2872-7. PubMed ID: 8428962 [TBL] [Abstract][Full Text] [Related]
18. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C. Petäjä J; Fernández JA; Gruber A; Griffin JH J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495 [TBL] [Abstract][Full Text] [Related]
20. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors. Rezaie AR; Esmon CT J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]